Eligible studies were randomised trials comparing cognitive therapy with another psychological treatment for people with a major depressive or dysthymic disorder. People with psychotic or bipolar disorders were excluded. 22 studies were included in the original meta-analysis, 10 of which used a 'bona fide' comparison group. Treatments were defined as 'bona fide' if the therapist was trained to provide therapy, held at least a masters degree or was enrolled in a relevant graduate programme; face to face meetings were used to develop a relationship; treatment was individualised for the participant rather than involving a rigid standard protocol, and therapy included psychologically valid components.
Study selection
Eligible studies were randomised trials comparing cognitive therapy with another psychological treatment for people with a major depressive or dysthymic disorder. People with psychotic or bipolar disorders were excluded. 22 studies were included in the original meta-analysis, 10 of which used a 'bona fide' comparison group. Treatments were defined as 'bona fide' if the therapist was trained to provide therapy, held at least a masters degree or was enrolled in a relevant graduate programme; face to face meetings were used to develop a relationship; treatment was individualised for the participant rather than involving a rigid standard protocol, and therapy included psychologically valid components.
Data extraction
Data were extracted on population, sample size, treatment characteristics and effect size. Larger studies were more heavily weighted when calculating aggregate effect sizes. Depression was assessed using the Beck Depression Inventory in all studies.
Main results
Cognitive therapy and 'other therapies' were equally effective for reducing depression scores. The aggregate effect size of cognitive therapy was 0.49 over non bona fide therapies (95% CI 0.28 to 0.69); 0.16 over bona fide therapies (95% CI -0.01 to 0.32), and 0.03 over bona fide therapies once a statistical outlier was removed (95% CI -0.15 to 0.2).
Conclusions
Previous meta-analyses suggested that cognitive therapy is more effective than other therapies for depression (excluding behaviour therapy). After accounting for 'control' treatments, this reanalysis found no evidence that cognitive therapy was more effective than other psychological therapies. The authors conclude that bona fide psychological treatments for depression are equally effective.
COMMENTARY
There is controversy over the relative efficacy of psychological therapies. 1 Some emphasize common features of psychotherapeutic techniques, particularly the quality of the therapeutic relationship, 2-3 while others explore the superiority of one technique over another. Cognitive behaviour therapy and interpersonal psychotherapy have been evaluated extensively and are often regarded as more 'evidencebased' than older therapies.
A range of therapies is probably needed to ensure the best match with an individual patient. Clarifying the 'added value' of any therapy over another for a particular individual and their therapist remains a research challenge. This paper contributes to the debate by offering a valid critique of Gloaguen et al's influential earlier meta-analysis. In contrast to the original findings, cognitive therapy was not superior to 'other therapies' once control treatments or apparently inadequate therapies were excluded. Although this reanalysis is interesting, it has several limitations:
i) The number of participants receiving other therapies was not large (n=265 in 9 studies in the final analysis). 4 ii) There was a small advantage to cognitive therapy until one of the original 10 studies was excluded as a statistical outlier.
iii) The most recent study was published in 1994. iv) 'Other approaches' included both individual and group treatments, ranging from psychodynamic models to highly structured interpersonal psychotherapy. v) As well as using the Beck Depression Inventory, other measures of psychosocial functioning and longer-term follow up may have revealed important differences.
The findings suggest that a range of treatments have similar therapeutic benefit. If recent breakdowns of the efficacy of 'cognitive' and 'behavioural' components of cognitive behavioural therapies are anything to go by, it will be difficult to identify the key elements of effective treatments. We cannot draw conclusions from this review about the relative merit of other therapies due to heterogeneity and the small number of studies. Unfortunately this does not assist us in selecting therapy for individual patients.
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